The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose ports are flushed with a combination of saline and heparinized saline.
The purpose of this study is to determine the safest and most effective flushing solution for maintaining patency (unobstructed flow) in implanted port catheters. The complication rate in patients whose ports are flushed with saline only will be compared to the complication rate in patients whose ports are flushed with a combination of saline and heparinized saline. These complications include partial or complete obstruction, infection of the central line, and/or the onset of heparin induced thrombocytopenia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
436
The control group will have their port catheters flushed with 20mL saline + 5mL heparin 100 units/mL; q 3 months
The intervention group will have their port catheters flushed with saline only.
UC Health Barrett Infusion Center
Cincinnati, Ohio, United States
TriHealth Cancer Institute Good Samaritan Infusion Center at GSH
Cincinnati, Ohio, United States
Ambulatory Treatment Center at Bethesda North TriHealth Hospital
Cincinnati, Ohio, United States
Number of Participants With First Complete Occlusion Within 1 Year
Number of participants who had a first complete occlusion (Blockage) within 1 year
Time frame: baseline to 1 year
Number of Participants With First Partial Occlusion Within 1 Year
Number of Participants with First Partial Occlusion (Blockage) within 1 year
Time frame: baseline to 1 year
Number of Participants With First Cathflo Administration for Occlusion (Blockage) Within 1 Year
Number of Participants with First Cathflo administration for Occlusion (Blockage) within 1 year
Time frame: baseline to 1 year
Number of Participants With First Complete or Partial Occlusion Within 1 Year
Number of Participants with either a First Complete or Partial Occlusion (Blockage) within 1 year
Time frame: baseline to 1 year
Number of Participants With HIT Within 1 Year
Heparin Induced Thrombocytopenia (HIT) as measured by a positive HIT antibody test, or any other heparin allergy, will be recorded.
Time frame: baseline to 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
TriHealth Cancer Institute Good Samaritan Infusion Center, Medicenter
Cincinnati, Ohio, United States
TriHealth Cancer Institute Good Samaritan Infusion Center, Cheviot
Cincinnati, Ohio, United States
TriHealth Cancer Institute Good Samaritan Infusion Center, Anderson
Cincinnati, Ohio, United States
TriHealth Cancer Institute Good Samaritan Infusion Center Butler County
Hamilton, Ohio, United States
McCullough Hyde Memorial Hospital Infusion Center
Oxford, Ohio, United States